3
|
Langerscheidt F, Wied T, Al Kabbani MA, van Eimeren T, Wunderlich G, Zempel H. Genetic forms of tauopathies: inherited causes and implications of Alzheimer's disease-like TAU pathology in primary and secondary tauopathies. J Neurol 2024; 271:2992-3018. [PMID: 38554150 PMCID: PMC11136742 DOI: 10.1007/s00415-024-12314-3] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/25/2024] [Revised: 03/06/2024] [Accepted: 03/07/2024] [Indexed: 04/01/2024]
Abstract
Tauopathies are a heterogeneous group of neurologic diseases characterized by pathological axodendritic distribution, ectopic expression, and/or phosphorylation and aggregation of the microtubule-associated protein TAU, encoded by the gene MAPT. Neuronal dysfunction, dementia, and neurodegeneration are common features of these often detrimental diseases. A neurodegenerative disease is considered a primary tauopathy when MAPT mutations/haplotypes are its primary cause and/or TAU is the main pathological feature. In case TAU pathology is observed but superimposed by another pathological hallmark, the condition is classified as a secondary tauopathy. In some tauopathies (e.g. MAPT-associated frontotemporal dementia (FTD), progressive supranuclear palsy (PSP), corticobasal degeneration (CBD), and Alzheimer's disease (AD)) TAU is recognized as a significant pathogenic driver of the disease. In many secondary tauopathies, including Parkinson's disease (PD) and Huntington's disease (HD), TAU is suggested to contribute to the development of dementia, but in others (e.g. Niemann-Pick disease (NPC)) TAU may only be a bystander. The genetic and pathological mechanisms underlying TAU pathology are often not fully understood. In this review, the genetic predispositions and variants associated with both primary and secondary tauopathies are examined in detail, assessing evidence for the role of TAU in these conditions. We highlight less common genetic forms of tauopathies to increase awareness for these disorders and the involvement of TAU in their pathology. This approach not only contributes to a deeper understanding of these conditions but may also lay the groundwork for potential TAU-based therapeutic interventions for various tauopathies.
Collapse
Affiliation(s)
- Felix Langerscheidt
- Institute of Human Genetics, Faculty of Medicine and University Hospital Cologne, University of Cologne, 50931, Cologne, Germany
- Center for Molecular Medicine Cologne (CMMC), University of Cologne, 50931, Cologne, Germany
| | - Tamara Wied
- Institute of Human Genetics, Faculty of Medicine and University Hospital Cologne, University of Cologne, 50931, Cologne, Germany
- Center for Molecular Medicine Cologne (CMMC), University of Cologne, 50931, Cologne, Germany
- Department of Natural Sciences, Bonn-Rhein-Sieg University of Applied Sciences, Von-Liebig-Str. 20, 53359, Rheinbach, Germany
| | - Mohamed Aghyad Al Kabbani
- Institute of Human Genetics, Faculty of Medicine and University Hospital Cologne, University of Cologne, 50931, Cologne, Germany
- Center for Molecular Medicine Cologne (CMMC), University of Cologne, 50931, Cologne, Germany
| | - Thilo van Eimeren
- Multimodal Neuroimaging Group, Department of Nuclear Medicine, Faculty of Medicine and University Hospital Cologne, University of Cologne, 50937, Cologne, Germany
- Department of Neurology, Faculty of Medicine and University Hospital Cologne, University of Cologne, 50937, Cologne, Germany
| | - Gilbert Wunderlich
- Department of Neurology, Faculty of Medicine and University Hospital Cologne, University of Cologne, 50937, Cologne, Germany
- Center for Rare Diseases, Faculty of Medicine and University Hospital Cologne, University of Cologne, 50931, Cologne, Germany
| | - Hans Zempel
- Institute of Human Genetics, Faculty of Medicine and University Hospital Cologne, University of Cologne, 50931, Cologne, Germany.
- Center for Molecular Medicine Cologne (CMMC), University of Cologne, 50931, Cologne, Germany.
| |
Collapse
|
5
|
Demortiere S, Joubert B, Benaiteau M, Hilezian F, Boutiere C, Rico A, Stolowy N, Dubois V, Audoin B, Maarouf A, Pelletier J. Anti-IgLON5 Disease With Inaugural Bilateral Neuropapillitis. Neurology 2024; 102:e209284. [PMID: 38527243 DOI: 10.1212/wnl.0000000000209284] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/16/2023] [Accepted: 01/22/2024] [Indexed: 03/27/2024] Open
Affiliation(s)
- Sarah Demortiere
- From the Department of Neurology (S.D., F.H., C.B., A.R., B.A., A.M., J.P.), Centre Hospitalier la Timone, Aix Marseille Univ; French Reference Center on Paraneoplastic Neurological Syndromes and Autoimmune Encephalitis (B.J., M.B., B.A., A.M., J.P.); Department of Neurology (B.J., M.B., B.A., A.M., J.P.), Centre Hospitalier Lyon Sud, Hospices Civils de Lyon; Department of Ophtalmology (N.S., B.A., A.M., J.P.), Centre Hospitalier la Timone, Aix Marseille Univ; Departement of Medical Biology (V.D., B.A., A.M., J.P.), Centre Hospitalier Lyon Sud, Hospices Civils de Lyon; and Aix Marseille Univ (B.A., A.M., J.P.), CNRS, CRMBM, Marseille, France
| | - Bastien Joubert
- From the Department of Neurology (S.D., F.H., C.B., A.R., B.A., A.M., J.P.), Centre Hospitalier la Timone, Aix Marseille Univ; French Reference Center on Paraneoplastic Neurological Syndromes and Autoimmune Encephalitis (B.J., M.B., B.A., A.M., J.P.); Department of Neurology (B.J., M.B., B.A., A.M., J.P.), Centre Hospitalier Lyon Sud, Hospices Civils de Lyon; Department of Ophtalmology (N.S., B.A., A.M., J.P.), Centre Hospitalier la Timone, Aix Marseille Univ; Departement of Medical Biology (V.D., B.A., A.M., J.P.), Centre Hospitalier Lyon Sud, Hospices Civils de Lyon; and Aix Marseille Univ (B.A., A.M., J.P.), CNRS, CRMBM, Marseille, France
| | - Marie Benaiteau
- From the Department of Neurology (S.D., F.H., C.B., A.R., B.A., A.M., J.P.), Centre Hospitalier la Timone, Aix Marseille Univ; French Reference Center on Paraneoplastic Neurological Syndromes and Autoimmune Encephalitis (B.J., M.B., B.A., A.M., J.P.); Department of Neurology (B.J., M.B., B.A., A.M., J.P.), Centre Hospitalier Lyon Sud, Hospices Civils de Lyon; Department of Ophtalmology (N.S., B.A., A.M., J.P.), Centre Hospitalier la Timone, Aix Marseille Univ; Departement of Medical Biology (V.D., B.A., A.M., J.P.), Centre Hospitalier Lyon Sud, Hospices Civils de Lyon; and Aix Marseille Univ (B.A., A.M., J.P.), CNRS, CRMBM, Marseille, France
| | - Frederic Hilezian
- From the Department of Neurology (S.D., F.H., C.B., A.R., B.A., A.M., J.P.), Centre Hospitalier la Timone, Aix Marseille Univ; French Reference Center on Paraneoplastic Neurological Syndromes and Autoimmune Encephalitis (B.J., M.B., B.A., A.M., J.P.); Department of Neurology (B.J., M.B., B.A., A.M., J.P.), Centre Hospitalier Lyon Sud, Hospices Civils de Lyon; Department of Ophtalmology (N.S., B.A., A.M., J.P.), Centre Hospitalier la Timone, Aix Marseille Univ; Departement of Medical Biology (V.D., B.A., A.M., J.P.), Centre Hospitalier Lyon Sud, Hospices Civils de Lyon; and Aix Marseille Univ (B.A., A.M., J.P.), CNRS, CRMBM, Marseille, France
| | - Clemence Boutiere
- From the Department of Neurology (S.D., F.H., C.B., A.R., B.A., A.M., J.P.), Centre Hospitalier la Timone, Aix Marseille Univ; French Reference Center on Paraneoplastic Neurological Syndromes and Autoimmune Encephalitis (B.J., M.B., B.A., A.M., J.P.); Department of Neurology (B.J., M.B., B.A., A.M., J.P.), Centre Hospitalier Lyon Sud, Hospices Civils de Lyon; Department of Ophtalmology (N.S., B.A., A.M., J.P.), Centre Hospitalier la Timone, Aix Marseille Univ; Departement of Medical Biology (V.D., B.A., A.M., J.P.), Centre Hospitalier Lyon Sud, Hospices Civils de Lyon; and Aix Marseille Univ (B.A., A.M., J.P.), CNRS, CRMBM, Marseille, France
| | - Audrey Rico
- From the Department of Neurology (S.D., F.H., C.B., A.R., B.A., A.M., J.P.), Centre Hospitalier la Timone, Aix Marseille Univ; French Reference Center on Paraneoplastic Neurological Syndromes and Autoimmune Encephalitis (B.J., M.B., B.A., A.M., J.P.); Department of Neurology (B.J., M.B., B.A., A.M., J.P.), Centre Hospitalier Lyon Sud, Hospices Civils de Lyon; Department of Ophtalmology (N.S., B.A., A.M., J.P.), Centre Hospitalier la Timone, Aix Marseille Univ; Departement of Medical Biology (V.D., B.A., A.M., J.P.), Centre Hospitalier Lyon Sud, Hospices Civils de Lyon; and Aix Marseille Univ (B.A., A.M., J.P.), CNRS, CRMBM, Marseille, France
| | - Natacha Stolowy
- From the Department of Neurology (S.D., F.H., C.B., A.R., B.A., A.M., J.P.), Centre Hospitalier la Timone, Aix Marseille Univ; French Reference Center on Paraneoplastic Neurological Syndromes and Autoimmune Encephalitis (B.J., M.B., B.A., A.M., J.P.); Department of Neurology (B.J., M.B., B.A., A.M., J.P.), Centre Hospitalier Lyon Sud, Hospices Civils de Lyon; Department of Ophtalmology (N.S., B.A., A.M., J.P.), Centre Hospitalier la Timone, Aix Marseille Univ; Departement of Medical Biology (V.D., B.A., A.M., J.P.), Centre Hospitalier Lyon Sud, Hospices Civils de Lyon; and Aix Marseille Univ (B.A., A.M., J.P.), CNRS, CRMBM, Marseille, France
| | - Valerie Dubois
- From the Department of Neurology (S.D., F.H., C.B., A.R., B.A., A.M., J.P.), Centre Hospitalier la Timone, Aix Marseille Univ; French Reference Center on Paraneoplastic Neurological Syndromes and Autoimmune Encephalitis (B.J., M.B., B.A., A.M., J.P.); Department of Neurology (B.J., M.B., B.A., A.M., J.P.), Centre Hospitalier Lyon Sud, Hospices Civils de Lyon; Department of Ophtalmology (N.S., B.A., A.M., J.P.), Centre Hospitalier la Timone, Aix Marseille Univ; Departement of Medical Biology (V.D., B.A., A.M., J.P.), Centre Hospitalier Lyon Sud, Hospices Civils de Lyon; and Aix Marseille Univ (B.A., A.M., J.P.), CNRS, CRMBM, Marseille, France
| | - Bertrand Audoin
- From the Department of Neurology (S.D., F.H., C.B., A.R., B.A., A.M., J.P.), Centre Hospitalier la Timone, Aix Marseille Univ; French Reference Center on Paraneoplastic Neurological Syndromes and Autoimmune Encephalitis (B.J., M.B., B.A., A.M., J.P.); Department of Neurology (B.J., M.B., B.A., A.M., J.P.), Centre Hospitalier Lyon Sud, Hospices Civils de Lyon; Department of Ophtalmology (N.S., B.A., A.M., J.P.), Centre Hospitalier la Timone, Aix Marseille Univ; Departement of Medical Biology (V.D., B.A., A.M., J.P.), Centre Hospitalier Lyon Sud, Hospices Civils de Lyon; and Aix Marseille Univ (B.A., A.M., J.P.), CNRS, CRMBM, Marseille, France
| | - Adil Maarouf
- From the Department of Neurology (S.D., F.H., C.B., A.R., B.A., A.M., J.P.), Centre Hospitalier la Timone, Aix Marseille Univ; French Reference Center on Paraneoplastic Neurological Syndromes and Autoimmune Encephalitis (B.J., M.B., B.A., A.M., J.P.); Department of Neurology (B.J., M.B., B.A., A.M., J.P.), Centre Hospitalier Lyon Sud, Hospices Civils de Lyon; Department of Ophtalmology (N.S., B.A., A.M., J.P.), Centre Hospitalier la Timone, Aix Marseille Univ; Departement of Medical Biology (V.D., B.A., A.M., J.P.), Centre Hospitalier Lyon Sud, Hospices Civils de Lyon; and Aix Marseille Univ (B.A., A.M., J.P.), CNRS, CRMBM, Marseille, France
| | - Jean Pelletier
- From the Department of Neurology (S.D., F.H., C.B., A.R., B.A., A.M., J.P.), Centre Hospitalier la Timone, Aix Marseille Univ; French Reference Center on Paraneoplastic Neurological Syndromes and Autoimmune Encephalitis (B.J., M.B., B.A., A.M., J.P.); Department of Neurology (B.J., M.B., B.A., A.M., J.P.), Centre Hospitalier Lyon Sud, Hospices Civils de Lyon; Department of Ophtalmology (N.S., B.A., A.M., J.P.), Centre Hospitalier la Timone, Aix Marseille Univ; Departement of Medical Biology (V.D., B.A., A.M., J.P.), Centre Hospitalier Lyon Sud, Hospices Civils de Lyon; and Aix Marseille Univ (B.A., A.M., J.P.), CNRS, CRMBM, Marseille, France
| |
Collapse
|
10
|
Gao Y, Li H, Luo H, Ni Y, Feng Y, He L, Zhou Q, Hu J, Chen S. Purified Serum IgG from a Patient with Anti-IgLON5 Antibody Cause Long-Term Movement Disorders with Impaired Dopaminergic Pathways in Mice. Biomedicines 2023; 11:2483. [PMID: 37760924 PMCID: PMC10526147 DOI: 10.3390/biomedicines11092483] [Citation(s) in RCA: 2] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/16/2023] [Revised: 08/24/2023] [Accepted: 08/30/2023] [Indexed: 09/29/2023] Open
Abstract
Background: Anti-IgLON5 disease is a rare autoimmune disease of the central nervous system. It typically manifests as a chronic condition, characterized by cognitive impairments, movement disorders, and sleep disorders. The mechanisms underlying movement disorders in this disease remain poorly understood due to a lack of research. Furthermore, this disease exhibits both neuroimmune and neurodegenerative characteristics. The objective of this study is to explore the underlying mechanisms of movement disorders caused by anti-IgLON5 antibodies for the first time. Methods: Antibodies were purified from the serum of a confirmed patient of anti-IgLON5 disease. The passive transfer animal models were employed, where antibodies were continuously injected into the substantia nigra pars compacta (SNc) of the mouse midbrain using stereotactic injection to explore the mechanism of movement disorder. The effects of anti-IgLON5 antibodies on dopaminergic neurons in the SNc and neurodegeneration were examined through immunohistochemistry. Changes in neurotransmitter levels in the basal ganglia were assessed using high-performance liquid chromatography. Additionally, RNA-seq was employed to identify the differentially expressed genes associated with the short-term and long-term effects of anti-IgLON5 antibody on the SNc. Results: Mice injected with anti-IgLON5 antibodies in the SNc exhibited persistent movement impairments for up to 3 months. One week after antibody injection, the number of TH neurons significantly decreased compared to the control group, accompanied by reduced projection fibers in the basal ganglia and decreased dopamine levels. After 3 months of antibody injection, an increase in phosphorylated Tau was observed in the SNc of the midbrain. Additionally, long-term sustained activation of microglia was detected in the SNc. The differentially expressed genes of long-term effects of IgLON5 antibodies were different from their short-term effects on the SNc. Conclusion: Purified serum IgG from a patient with anti-IgLON5 antibodies can cause long-term movement disorder in mice. The movement disorders appear to be linked to the impaired dopaminergic pathway, and the increased p-Tau showed neurodegenerative changes induced by the anti-IgLON5 antibody.
Collapse
Affiliation(s)
- Yining Gao
- Department of Neurology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200023, China; (Y.G.); (H.L.); (Y.N.); (L.H.); (Q.Z.)
| | - Hongxia Li
- Department of Neurology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200023, China; (Y.G.); (H.L.); (Y.N.); (L.H.); (Q.Z.)
| | - Huoqing Luo
- School of Life Science and Technology, ShanghaiTech University, Shanghai 201210, China; (H.L.); (Y.F.)
| | - You Ni
- Department of Neurology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200023, China; (Y.G.); (H.L.); (Y.N.); (L.H.); (Q.Z.)
| | - Yifan Feng
- School of Life Science and Technology, ShanghaiTech University, Shanghai 201210, China; (H.L.); (Y.F.)
| | - Lu He
- Department of Neurology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200023, China; (Y.G.); (H.L.); (Y.N.); (L.H.); (Q.Z.)
| | - Qinming Zhou
- Department of Neurology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200023, China; (Y.G.); (H.L.); (Y.N.); (L.H.); (Q.Z.)
| | - Ji Hu
- School of Life Science and Technology, ShanghaiTech University, Shanghai 201210, China; (H.L.); (Y.F.)
- Co-Innovation Center of Neuroregeneration, Nantong University, Nantong 226007, China
| | - Sheng Chen
- Department of Neurology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200023, China; (Y.G.); (H.L.); (Y.N.); (L.H.); (Q.Z.)
- Co-Innovation Center of Neuroregeneration, Nantong University, Nantong 226007, China
| |
Collapse
|